Caas Capital Management LP Maravai Lifesciences Holdings, Inc. Transaction History

Caas Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$12.5 - $24.78 $425,000 - $842,520	34,000 New	34,000 $486,000
Q4 2021 Feb 14, 2022	SELL	$35.0 - $45.94 $18.2 Million - $23.8 Million	-518,745 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$36.8 - $60.62 $19.1 Million - $31.4 Million	518,745 New	518,745 $25.5 Million
Q1 2021 May 17, 2021	SELL	$25.8 - $38.49 $18.1 Million - $26.9 Million	-700,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$24.5 - $30.86 $17.2 Million - $21.6 Million	700,000 New	700,000 $19.6 Million

234

140M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $738M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.